Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05184712
Title Phase 3 Clinical Study of AK112 for NSCLC Patients
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Summit Therapeutics
Age Groups: adult | senior
Covered Countries

No variant requirements are available.